The echinocandin B producer fungus Aspergillus nidulans var. roseus ATCC 58397 does not possess innate resistance against its lipopeptide antimycotic

Applied Microbiology and Biotechnology
Viktória TóthT Emri

Abstract

Aspergillus nidulans var. roseus ATCC 58397 is an echinocandin B (ECB) producer ascomycete with great industrial importance. As demonstrated by ECB/caspofungin sensitivity assays, A. nidulans var. roseus does not possess any inherent resistance to echinocandins, and its tolerance to these lipopeptide antimycotics are even lower than those of the non-producer A. nidulans FGSC A4 strain. Under ECB producing conditions or ECB exposures, A. nidulans var. roseus induced its ECB tolerance via up-regulating elements of the chitin biosynthetic machinery and, hence, through changing dynamically the composition of its own cell wall. Importantly, although the specific β-1,3-glucan synthase activity was elevated, these changes reduced the β-glucan content of hyphae considerably, but the expression of fksA, encoding the catalytic subunit of β-1,3-glucan synthase, the putative target of echinocandins in the aspergilli, was not affected. These data suggest that compensatory chitin biosynthesis is the centerpiece of the induced ECB tolerance of A. nidulans var. roseus. It is important to note that the induced tolerance to ECB (although resulted in paradoxical growth at higher ECB concentrations) was accompanied with reduced growth rate and, un...Continue Reading

References

Jan 1, 1992·Journal of Bacteriology·P T Borgia, C L Dodge
Jun 15, 1997·Analytical Biochemistry·E ShedletzkyD P Delmer
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·S ArikanJ H Rex
Jun 14, 2001·Systematic and Applied Microbiology·M KlichJ W Bennett
Jun 1, 2002·The Journal of Antimicrobial Chemotherapy·David W Denning
Dec 31, 2002·The Annals of Pharmacotherapy·Staci A Pacetti, Steven P Gelone
Sep 11, 2003·Advances in Applied Microbiology·Kevin McCluskey
Dec 10, 2003·Journal of Clinical Microbiology·Michael A PfallerDaniel J Diekema
Sep 29, 2004·The Journal of Cell Biology·Paola FabrizioValter D Longo
Apr 7, 2005·Journal of Basic Microbiology·László GalgóczyCsaba Vágvölgyi
Jun 16, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·David S Perlin
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Maiken Cavling ArendrupCornelia Lass-Flörl
Sep 4, 2008·Fungal Genetics and Biology : FG & B·Armêl PlaineMathias L Richard
Oct 24, 2008·Phytopathology·Ana Beatriz MorenoBlanca San Segundo
Mar 4, 2009·Medical Mycology·Nathan P Wiederhold
Sep 23, 2009·Fungal Genetics and Biology : FG & B·Louise A WalkerCarol A Munro
Aug 28, 2010·Medical Mycology·Susan Julie Howard, Maiken Cavling Arendrup
Feb 24, 2011·The Journal of Biological Chemistry·Jean Paul OuedraogoVera Meyer
Aug 23, 2011·Folia Microbiologica·Viktória TóthTamás Emri

❮ Previous
Next ❯

Citations

Mar 7, 2013·Applied Microbiology and Biotechnology·Tamás EmriIstván Pócsi
Dec 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiaohan WangLigang Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.